Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BAFNAPH.NSthis companyBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
BRBROOKS.BOBrooks Laboratories Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BROOKS.NSBrooks Laboratories Limited	₹65.75	4.44×	0.89×	1.27×	4.08×	-153.4%	21.0%	6.4%	28.7%	20.0%	4.1%	4.7%	0.07×	0.04×	6.55×	1.72×	0.0%	4	—	2	B-
MEMEDICO.BOMedico Remedies Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
MEDICO.NSMedico Remedies Limited	₹18.88	20.73×	3.6×	1.32×	12.6×	-8.6%	21.6%	6.8%	6.4%	17.4%	10.7%	-1.3%	0.25×	0.75×	7.71×	1.66×	0.0%	4	—	2	B-
NENECLIFE.BONectar Lifesciences Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	12.59×	2.25×	1.3×	8.34×	-81.0%	21.3%	6.6%	17.5%	18.7%	7.4%	1.7%	0.16×	0.39×	7.13×	1.69×	0.0%	4	—	2	—